Skip to main content

Table 2 Treatment

From: Paediatric non-infectious uveitis in Cape Town, South Africa: a retrospective review of disease characteristics and outcomes on immunomodulating treatment

Treatment Total treated
N
Response
(R) / No
Response (NR)
JIAU N = 14 Idiopathic N = 12 Sarcoidosis
N = 2
Behcet’s Disease
N = 1
Total N (%)
Screening
N = 11
Pre-JIA diagnosis N = 3
Standard Initial Rx 29 R 7 1 6 2 1 17 (58.6)
NR 4 2 6 0 0 12 (41.4)
Azathioprine 8 R 1 0 1 (12.5)
NR 3 4 7 (87.5)
Mycophenolate Mofetil 3 R 1 0 1 (33.3)
NR 1 1 2 (66.6)
Infliximab 6 R 1 0 1 2 (33.3)
NR 1 1 1 3 (50)
Adalimumab 8 R 1 2 4 7 (87.5)
NR 0 0 1 1 (12.5)
Surgery: no. of children N (%) 2 1 9 0 0 12 (41.4)
No. of procedures
Cataract incl. Pars planar vitrectomy/ lensectomy 2 1 10 0 0 13
Corneal chelation 0 0 2 0 0 2
Evisceration 0 0 1 0 0 1
  1. Responders (R) had inactive disease on treatment. In non-responders (NR), treatment was escalated to one of the additional DMARDs then a TNFi or directly to a TNFi